IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today reported that an overview of the Company’s business strategy will be given at the Jefferies 2010 Global Specialty Pharma & European Healthcare Conference, being held in London, England. The Spectrum Pharmaceuticals presentation is at 11:30a.m. London Time on Tuesday, October 5, 2010.
